Trials / Unknown
UnknownNCT04899583
ACOART SCB BIF: Treatment of Coronary Bifurcation Lesion by Sirolimus Coated Balloon vs Paclitaxel Coated Balloon
A Prospective, Multicenter, Random Controlled Clinical Trail to Evaluate the Effectiveness and Safety of Sirolimus Coated Balloon Versus a Paclitaxel Coated Balloon in the Treatment of Coronary Bifurcation Lesion
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 230 (estimated)
- Sponsor
- Acotec Scientific Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this randomized controlled trial is to examine the treatment of coronary bifurcation lesion with a sirolimus coated balloon versus a paclitaxel coated balloon. This trial is designed as prospective, multicenter, randomized and open-label.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sirolimus Coated Balloon Catheter | a Sirolimus Coated Balloon Catheter designed and produced by Acotec |
| DEVICE | a Paclitaxel Coated Balloon Catheter | a Paclitaxel Coated Balloon Catheter(trade name:Bingo) |
Timeline
- Start date
- 2021-11-10
- Primary completion
- 2024-11-01
- Completion
- 2025-11-01
- First posted
- 2021-05-24
- Last updated
- 2023-11-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04899583. Inclusion in this directory is not an endorsement.